CIK 0001109354
- Large accelerated filer
BRUKER CORP
Sign in to watch- Ticker
- BRKR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043110160
- Phone
- +1 978-663-3660
- Business address
- 40 MANNING RD, BILLERICA, MA, 01821
- Former names
- BRUKER BIOSCIENCES CORP, BRUKER DALTONICS INC
Securities
- BRKR Common Stock Nasdaq
- BRKRP 6.375% Mandatory Convertible Preferred Stock, Series A Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $105,740
- in 1 filing
Net −$105,740. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-06 | Busse Falko President, BioSpin Group | Grant or award | +5,173 | 20,354 | ||
| 2020-08-06 | Busse Falko President, BioSpin Group | Grant or award · Stock Option (Right to Buy) | +5,828 | 5,828 | ||
| 2020-08-06 | LAUKIEN FRANK H CEO, President | Grant or award | +52,248 | 38,120,873 | ||
| 2020-08-06 | LAUKIEN FRANK H CEO, President | Grant or award · Stock Option (Right to Buy) | +58,867 | 58,867 | ||
| 2020-06-22 | Friend Cynthia M Director | Sale | −1,800 | $40.57 | $73K | 11,857 |
| 2020-05-11 | Friend Cynthia M Director | Sale | −1,000 | $39.06 | $39K | 13,657 |
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion | +10,000 | $21.74 | $217K | 24,657 |
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion | +10,000 | $19.12 | $191K | 34,657 |
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion | +10,000 | $24.00 | $240K | 44,657 |
| 2020-05-11 | Martin Gilles Gerard Jean Director | Sale | +30,000 | $38.83 | $1.2M | 14,657 |
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion · Stock Option (Right to Purchase) | −10,000 | 0 | ||
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion · Stock Option (Right to Purchase) | −10,000 | 0 | ||
| 2020-05-11 | Martin Gilles Gerard Jean Director | Exercise or conversion · Stock Option (Right to Purchase) | −10,000 | 0 | ||
| 2020-05-11 | LAUKIEN FRANK H CEO, President | Purchase | +2,500 | $39.11 | $98K | 38,068,625 |
| 2020-03-24 | LAUKIEN FRANK H CEO, President | Exercise or conversion | +25,000 | $24.41 | $610K | 38,066,125 |
| 2020-03-24 | LAUKIEN FRANK H CEO, President | Exercise or conversion · Stock option - right to purchase | −25,000 | 0 | ||
| 2020-01-06 | ROSENTHAL BOB Director | Grant or award | +2,472 | 14,657 | ||
| 2020-01-06 | Requardt Hermann Fritz Director | Grant or award | +2,472 | 14,657 | ||
| 2020-01-06 | Perkins Adelene Q Director | Grant or award | +2,472 | 12,836 | ||
| 2020-01-06 | PACKER RICHARD A Director | Grant or award | +2,472 | 55,764.02 |
Page 21 of 39 · 771 trades